Standout Papers

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Pa... 2004 2026 2011 2018 932
  1. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients (2004)
    Francesca J. Torriani, M. Rodríguez‐Torres et al. New England Journal of Medicine

Immediate Impact

6 by Nobel laureates 6 from Science/Nature 84 standout
Sub-graph 1 of 19

Citing Papers

Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
2017 Standout
20 intermediate papers

Works of Hoel Sette being referenced

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients
2004 Standout
Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose
2002
and 2 more

Author Peers

Author Last Decade Papers Cites
Hoel Sette 1457 1247 58 460 32 1.7k
Francesca Cainelli 981 1136 24 316 48 2.0k
Patrick Miailhes 842 969 38 370 81 1.4k
P Dentico 1095 1225 71 226 73 1.7k
Ángela Camacho 1263 980 18 515 95 1.7k
Juraj Petrík 903 753 22 325 56 1.6k
Y. Benhamou 1220 1258 18 331 60 1.7k
Gabriella Verucchi 1464 1437 20 277 86 2.0k
Sylvie Deuffic‐Burban 1310 1509 15 610 79 2.1k
Joe Sasadeusz 1067 1559 30 541 86 1.9k
Archana Sud 789 1179 147 292 39 1.8k

All Works

Loading papers...

Rankless by CCL
2026